Feb 13, 2026

BlackRock Raises BitMine Immersion Technologies Stake to Over 9 Million Shares

TLDR: BlackRock increased BitMine holdings to 9,049,912 shares, up 165.6% from last quarter The total position is valued at roughl...

Feb 13, 2026

Best Crypto to Buy Now February 13 – XRP, Solana, PEPE

The best crypto investors don’t panic during market pullbacks, they prepare. History shows that periods of weakness are the most p...

Feb 13, 2026

Trump-linked Truth Social seeks SEC approval for two crypto ETFs

The filings include a bitcoin and ether ETF and a staking-focused Cronos fund, deepening the Truth Social brand’s ambitions in dig...

Feb 13, 2026

Crypto group counters Wall Street bankers with its own stablecoin principles for...

After the bankers shared a document at the White House demanding a total ban on stablecoin yield, the crypto side answers that it...

Feb 13, 2026

Wall Street analysts slash Coinbase price targets after Q4 miss — but shares ral...

Barclays, Benchmark, Clear Street, and JPMorgan all cut targets, citing weak retail trading and macro headwinds.

Feb 13, 2026

U.S.-based DeFi group urges UK FCA to anchor crypto rules to 'unilateral control...

DeFi Education Fund says developers of non-custodial protocols should not be regulated as intermediaries under the U.K.’s proposed...

Feb 13, 2026

Ethereum Foundation leadership shake-up: Tomasz Stańczak out as co-executive dir...

Stańczak came aboard in 2025 after the exit of longtime chief Aya Miyaguchi amid criticism the foundation wasn’t doing enough to p...

Feb 13, 2026

Tesla (TSLA) Stock Down 16% From All-Time Highs – Should Investors Buy the Dip?

TLDR Tesla stock dropped 2.7% Thursday, ending a four-day winning streak, and fell another 0.7% in Friday premarket trading to $41...

Feb 13, 2026

Why Amazon (AMZN) and Microsoft (MSFT) Stocks Just Crashed into Bear Market Terr...

TLDR Amazon and Microsoft have entered bear market territory, both down over 20% from recent highs due to concerns about heavy AI...

Feb 13, 2026

Moderna (MRNA) Stock Slips Despite Beating Q4 Revenue and Earnings Estimates

TLDR Moderna reported Q4 revenue of $678 million, beating Wall Street estimates of $626.1 million, driven by COVID-19 vaccine sale...